Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Filings indexed 2,479 across all filing types
Latest filing 2020-11-03 Annual Report
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20
Annual Report Classification · 1% confidence The document is clearly identified as an 'Annual Report' by its explicit title, the inclusion of a five-year financial highlights table, a table of contents covering management reports, financial statements, and auditor reports, as well as letters from the Chairman and CEO. It contains comprehensive financial data and performance analysis for the 2019/20 fiscal year, fitting the definition of a 10-K (Annual Report). FY 2020
2020-11-03 English
Coloplast A/S - Announcement no. 10/2020 - Full-year Financial Results 2019/20
Earnings Release Classification · 1% confidence The document is titled 'Årsregnskabsmeddelelse 2019/20' (Annual Financial Announcement) for Coloplast A/S. It provides a summary of the full-year financial results, including revenue, organic growth, operating profit, and future guidance. While it contains detailed financial highlights, it is structured as a corporate announcement (Selskabsmeddelelse) and explicitly includes a link to a separate 'Vedhæftet fil' (attached file) for the full report. Following the 'Menu vs Meal' rule, this document serves as the initial release/announcement of the annual financial results rather than the full 10-K/Annual Report document itself. FY 2020
2020-11-03 Danish
Coloplast A/S - Announcement no. 10/2020 - Full-year Financial Results 2019/20
Earnings Release Classification · 1% confidence The document is a detailed financial announcement from Coloplast (Announcement no. 10/2020) covering full-year financial results for 2019/20. It includes income statements, balance sheets, sales performance by region and business area, and management commentary on financial guidance. It is not a full 10-K (Annual Report) but rather the initial release of financial results, which fits the definition of an Earnings Release (ER). FY 2019
2020-11-03 English
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is explicitly titled "Coloplast A/S - Announcement no. 10/2020 - Full-year Financial Results 2019/20" and contains detailed financial figures (revenue, EBIT margin, ROIC) for the full fiscal year (01 October 2019 - 30 September 2020). It also provides financial guidance for the next year and announces the dividend recommendation. This content strongly indicates a primary release of annual financial performance. Although it mentions a conference call and has an attachment, the core content is the summary of the full-year results, which aligns best with the 'Earnings Release' (ER) category, as it is the initial announcement of the full-year results, even though it covers the full year rather than a quarter. The 10-K is the formal SEC filing, whereas this is the company's press release summarizing those results. Since it is a comprehensive summary of the full year's performance, ER is the most appropriate fit among the options provided for an initial results announcement. FY 2020
2020-11-03 English
Earnings Release 2020
Earnings Release Classification · 1% confidence The document is titled "2019/20 Årsregnskabsmeddelelse 2019/20" (Annual Financial Statement Announcement 2019/20) and contains comprehensive financial data, key performance indicators (KPIs) for the full fiscal year (1. oktober 2019 – 30. september 2020), segment breakdowns, balance sheet figures, and forward-looking guidance for the next year (2020/21). The content is clearly a detailed report of annual financial performance, including an income statement, balance sheet, and cash flow summary. Although it is an 'announcement' (Meddelelse), its length (over 100,000 characters) and depth of financial detail strongly indicate it is the full Annual Report content, not just a brief RPA/RNS announcement. In the context of the provided definitions, this aligns best with the comprehensive nature of an Annual Report (10-K), even though the specific regulatory form name '10-K' is not used, as it covers the full fiscal year performance. FY 2020
2020-11-03 Danish
Coloplast A/S - Announcement no. 09/2020 - Coloplast launches new 2025 strategy and provides new long-term financial guidance of 7-9% organic revenue growth and an EBIT margin of more than 30%
Investor Presentation Classification · 1% confidence The document is a corporate announcement (Selskabsmeddelelse) from Coloplast regarding their 'Capital Markets Day' and the launch of their 'Strive25' strategy. It outlines long-term financial and non-financial goals, provides context for the event, and lists the presenters. While it contains strategic information, it is primarily an announcement of an investor event and the publication of a new strategy, rather than a full investor presentation deck itself. Given the structure and content, it fits best as an Investor Presentation (IP) related announcement or a general regulatory filing. However, since it details the strategic goals and financial expectations for the 2025 period, it is most accurately classified as an Investor Presentation (IP) document.
2020-09-29 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.